This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Diabetes Mellitus, Type 1
+4

Gastric Pathophysiology in Diabetes

Sponsored by Institute for Clinical and Experimental Medicine

About this trial

Last updated 2 years ago

Study ID

DiaFLIP

Status

Recruiting

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
18 to 70 Years
All
All

Trial Timing

Started 3 years ago

What is this trial about?

This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated. For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.

What are the Participation Requirements?

Inclusion Criteria (diabetic group):

- Diabetes mellitus type I or II, minimal duration of the disease 3 years, minimal
duration of specific treatment (drugs, insulin) 2 years

Exclusion Criteria (diabetic group):

- Diabetes mellitus type II being treated with a diet only

- Severe acute decompensation of diabetes (uncontrolled diabetes) necessitating
hospitalization

- Concomitant treatment with more than one prokinetic agent

- Active treatment with opioids or a history of treatment with opioids within 12 months
before enrolment

- Previous esophageal or major gastric surgery (e.g. esophageal myotomy, esophagectomy,
antireflux surgery, Billroth I or II gastric resection, gastric pull-through,
pyloromyotomy, pyloroplasty, gastric electrical stimulation)

- Organic pyloric (or intestinal) obstruction (fibrotic stricture, etc.)

- Severe coagulopathy

- Esophageal or gastric varices and /or portal gastropathy

- Advanced liver cirrhosis

- Pregnancy or puerperium

- Malignant or pre-malignant gastric diseases (dysplasia, gastric cancer, GIST):
patients with a history of such disease after its cure are eligible for enrolment

- The presence of a rumination syndrome or eating disorders (anorexia nervosa, bulimia).
In case of doubts, a psychiatric examination will be performed.

- Systemic connective tissue disorder

- Inability to obtain informed consent

- Any other condition, which in the opinion of the investigator would interfere with
study requirements

Locations

Location

Status

Recruiting
Recruiting